DTU Bioengineering offers a PhD scholarship aimed at improving the production efficiency of complex biotherapeutics such as monoclonal antibodies and gene therapies using single-cell technologies. The project involves engineering mammalian cells to enhance their metabolic and production capabilities through the analysis of single-cell transcriptomic data. The ideal candidate will have a two-year master's degree (120 ECTS) or equivalent, with experience in mammalian cell culture, molecular biology techniques like CRISPR and gene editing, and ideally familiarity with scRNA-Seq data and Python. The position offers the opportunity to work independently on scientific experiments, collaborate with a research group, and engage with external partners
